COST-EFFECTIVENESS OF ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS B: A SYSTEMATIC REVIEW

被引：1
|
作者：
Chen, W. [1 ]
Tang, Z. [2 ]
Wang, X. [2 ]
Li, J. [3 ]
Luo, Z. [3 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Bristol Myers Squibb Co, Shanghai, Peoples R China
[3] Normin Hlth Changsha Representat Off, Changsha, Hunan, Peoples R China
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.518
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN18
引用
收藏
页码：A805 / A805
页数：1
相关论文
共 50 条
  • [1] Comparative cost-effectiveness of antiviral therapies in patients with chronic hepatitis B: A systematic review of economic evidence
    Sun, Xin
    Qin, Wen-Xia
    Li, You-Ping
    Jiang, Xu-Hua
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (09) : 1369 - 1377
  • [2] Cost-effectiveness analysis of antiviral therapies for chronic hepatitis B in Taiwan
    Chan, KA
    Pwu, RF
    [J]. VALUE IN HEALTH, 2003, 6 (03) : 263 - 263
  • [3] Cost Effectiveness of First-Line Oral Antiviral Therapies for Chronic Hepatitis B A Systematic Review
    Buti, Maria
    Oyagueez, Itziar
    Lozano, Virginia
    Casado, Miguel A.
    [J]. PHARMACOECONOMICS, 2013, 31 (01) : 63 - 75
  • [4] Cost Effectiveness of First-Line Oral Antiviral Therapies for Chronic Hepatitis B A Systematic Review
    María Buti
    Itziar Oyagüez
    Virginia Lozano
    Miguel A. Casado
    [J]. PharmacoEconomics, 2013, 31 : 63 - 75
  • [5] SYSTEMATIC REVIEW OF INDIVIDUAL-LEVEL SIMULATION IN COST-EFFECTIVENESS ANALYSIS OF ANTIVIRAL TREATMENTS IN PATIENTS WITH HEPATITIS B
    Lee, H.
    Kim, A. Y.
    Cho, Y.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S125 - S125
  • [6] Modeling the cost-effectiveness of different oral antiviral therapies in patients with chronic hepatitis B
    Buti, Maria
    Brosa, Max
    Casado, Miguel A.
    Rueda, Magdalena
    Esteban, Rafael
    [J]. JOURNAL OF HEPATOLOGY, 2009, 51 (04) : 640 - 646
  • [7] Application of Bayesian Approach to Cost-Effectiveness Analysis of Antiviral Treatments in Chronic Hepatitis B
    Zhang, Hua
    Huo, Mingdong
    Chao, Jianqian
    Liu, Pei
    [J]. PLOS ONE, 2016, 11 (08):
  • [8] Cost-Effectiveness of Elbasvir/Grazoprevir for the Treatment of Chronic Hepatitis C: A Systematic Review
    Liu, Jinyu
    Guo, Min
    Ke, Lei
    You, Ruxu
    [J]. FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [9] COST EFFECTIVENESS OF TENOFOVIR FOR THE TREATMENT OF CHRONIC HEPATITIS B A SYSTEMATIC REVIEW
    Balbinot, J. C.
    Wiens, A.
    Pontarolo, R.
    Sanches, A. C.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A867 - A867
  • [10] Cost-Effectiveness Analysis of Antiviral Therapy for Untreated Minimally Active Chronic Hepatitis B to Prevent Liver Disease Progression
    Lee, Hankil
    Kim, Beom Kyung
    Jang, Sungin
    Ahn, Sang Hoon
    [J]. CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2021, 12 (02) : E00299
12345